SIGNATUREFD, LLC

Position in DYN — Dyne Therapeutics, Inc.

CIK 1456048 ATLANTA, GA

Position in DYN

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$9,328

+$4,288 QoQ

Shares Held

420

+51.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#205

of 245 holders

Holding Since

Sep 2021

18 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

SIGNATUREFD, LLC holds $13,806,120 across 160 Biotechnology names. DYN ranks #97 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	5,593	$2,778,210
2	ARGX	Argenx SE	2,075	$1,925,122
3	REGN	Regeneron Pharmaceuticals, Inc.	1,756	$1,094,936
4	ALNY	Alnylam Pharmaceuticals, Inc.	2,063	$621,024
5	INCY	Incyte Corp	4,178	$473,618
6	GMAB	Genmab A/S	16,442	$451,661
7	EXEL	Exelixis, Inc.	7,184	$390,881
8	PCVX	Vaxcyte, Inc.	6,510	$378,426

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,328	420	+51.1%	Shares	Sole	2026-07-24
2026-03-31	$5,040	278	-13.1%	Shares	Sole	2026-04-07
2025-12-31	$6,259	320	+15.1%	Shares	Sole	2026-01-20
2025-09-30	$3,516	278	-4.1%	Shares	Sole	2025-10-21
2025-06-30	$2,760	290	-60.3%	Shares	Sole	2025-07-16
2025-03-31	$7,646	731	+22.2%	Shares	Sole	2025-05-02
2024-12-31	$14,088	598	-14.2%	Shares	Sole	2025-02-10
2024-09-30	$25,036	697	+9.1%	Shares	Sole	2024-10-21
2024-06-30	$22,550	639	+6.9%	Shares	Sole	2024-07-29
2024-03-31	$16,977	598	+3.3%	Shares	Sole	2024-05-03
2023-12-31	$7,700	579	+421.6%	Shares	Sole	2024-02-01
2023-09-30	$994	111	-48.1%	Shares	Sole	2023-11-03
2023-06-30	$2,407	214	+12.0%	Shares	Sole	2023-08-01
2023-03-31	$2,200	191	0.0%	Shares	Sole	2023-04-28
2022-12-31	$2,213	191	0.0%	Shares	Sole	2023-01-30
2022-09-30	$2,425	191	+169.0%	Shares	Sole	2022-11-08
2022-03-31	$684	71	+44.9%	Shares	Sole	2022-05-02
2021-09-30	$795	49	—	Shares	Sole	2021-10-28
No filing history on record for this holder in this stock.